Health care stocks were rising Friday afternoon, with the NYSE Health Care Index adding 0.8% and the Health Care Select Sector SPDR Fund (XLV) up 0.3%.
The iShares Biotechnology ETF (IBB) eased 0.3%.
In corporate news, Novo Nordisk (NVO) shares jumped 8.2% after it said Friday that its investigative weight loss drug amycretin led to a body weight reduction of up to 22% in an early-stage trial.
HCA Healthcare (HCA) reported Q4 adjusted earnings Friday of $6.22 per diluted share, up from $5.90 a year earlier. Revenue for the quarter was $18.29 billion, up from $17.30 billion a year earlier. Its shares were shedding 3.5%.
Allurion Technologies (ALUR) shares surged past 122%. The company said Friday that it signed a definitive agreement with institutional investors for the sale of 1.24 million common shares at $6 per share through a registered direct offering for proceeds of $7.4 million.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。